EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent models

Massimo Saini, Francesc Castro-Giner, Adriana Hotz, Magdalena K Sznurkowska, Manuel Nüesch, François M Cuenot, Selina Budinjas, Gilles Bilfeld, Ece Su Ildız, Karin Strittmatter, Ilona Krol, Zoi Diamantopoulou und 7 weitere

Cell · 2025-12 · 188 (26) · 7591-7609.e32

DOI: 10.1016/j.cell.2025.10.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025-12. Verfasst von Massimo Saini und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Neoplasm Metastasis, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Krebsliga Schweiz, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR screens have become standard gene discovery platforms in various contexts, including cancer. Yet commonly available CRISPR-Cas9 tools are increasingly recognized as unfit for in vivo investigations in immunocompetent contexts, due to broad immunogenicity of bacterial nucleases and reporters. Here, we show how conventional CRISPR screens in tumor grafts are systematically jeopardized by immunoediting in syngeneic and humanized immunocompetent hosts, resulting in iatrogenic clonal dropouts and ultimately compromising target identification. To resolve this, we present StealTHY, an immunogen-free CRISPR platform compatible with virtually all immunocompetent designs, enabling preservation of clonal architecture and exposing previously concealed cancer vulnerabilities. Among these, we identify the AMH-AMHR2 axis as a formerly unappreciated metastasis target. Thus, with StealTHY, we provide a new resource to expand the applicability of CRISPR screens to immunocompetent models, including humanized tumor grafts, revealing metastasis regulators of therapeutic relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsNeoplasm MetastasisNeoplasmsAnimalsHumansMiceCell Line, TumorImmunocompetenceMice, Inbred C57BLFemale

Stichwörter der Autor:innen

CRISPRCas9anti-tumor immunitycancercancer immunogenicityhumanized micemetastasispatient-derived xenograftspreclinical models of cancer

Autor:innen und Institutionen

  • Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland.
  • Functional Genomics Center Zurich, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland.
  • Department of Biomedicine, University of Basel and University Hospital Basel, 4058 Basel, Switzerland.
  • Functional Genomics Center Zurich, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland; Genome Engineering and Measurement Laboratory (GEML), Swiss Federal Institute of Technology (ETH) Zurich,…
  • Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland. Electronic address: naceto@ethz.ch.

Förderung

  • Krebsliga Schweiz
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • European Research Council
  • Swiss Cancer Research Foundation
  • H2020 Future and Emerging Technologies
  • Swiss Cancer Foundation
  • Eidgenössische Technische Hochschule Zürich
  • Schweizerische Akademie der Medizinischen Wissenschaften

Zitieren

APA

Saini, M., Castro-Giner, F., Hotz, A., Sznurkowska, M. K., Nüesch, M., Cuenot, F. M., Budinjas, S., Bilfeld, G., Ildız, E. S., Strittmatter, K., Krol, I., Diamantopoulou, Z., Paasinen-Sohns, A., Waldmeier, M., Cássio, R., Kreutzer, S., Kontarakis, Z., Gvozdenovic, A., & Aceto, N. (2025). StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent models. Cell, 188(26), 7591-7609.e32. https://doi.org/10.1016/j.cell.2025.10.007

Vancouver

Saini M, Castro-Giner F, Hotz A, Sznurkowska MK, Nüesch M, Cuenot FM, et al. StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent models. Cell. 2025;188(26):7591-7609.e32. doi:10.1016/j.cell.2025.10.007

BibTeX
@article{Saini2025,
  author = {Saini, Massimo and Castro-Giner, Francesc and Hotz, Adriana and Sznurkowska, Magdalena K and Nüesch, Manuel and Cuenot, François M and Budinjas, Selina and Bilfeld, Gilles and Ildız, Ece Su and Strittmatter, Karin and Krol, Ilona and Diamantopoulou, Zoi and Paasinen-Sohns, Aino and Waldmeier, Maria and Cássio, Rafaela and Kreutzer, Susanne and Kontarakis, Zacharias and Gvozdenovic, Ana and Aceto, Nicola},
  title = {StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent models},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {26},
  pages = {7591--7609.e32},
  doi = {10.1016/j.cell.2025.10.007}
}
Kostenlos starten →